Labs / CDMO: development & manufacturing
Aarti Pharmalabs Limited
Mumbai, India · aartipharmalabs.com
Aarti Pharmalabs Limited develops and manufactures APIs, NCEs, HPAPIs, peptides, oligos, payload-linker conjugates, intermediates, RSMs, KSMs, and key building blocks for clinical development and commercial production. It serves pharmaceutical and biotechnology companies from sites in Gujarat and Maharashtra, India, with products exported to regulated markets including the USA, the European Union, and Japan.
They take quote requests by email.
What they offer
Small Molecules CDMO
Provides end-to-end CMC services for critical drug substances from laboratory benchwork and pilot scale through clinical trials, launch, and commercial manufacturing.
Peptides & Oligos (TIDES)
Develops and manufactures peptide and oligonucleotide programs as part of its CDMO offering.
Payload-Linker Conjugates
Supports development and manufacturing of payload-linker conjugates, including dedicated OEB-6 laboratory expansion.
HPAPIs
Develops and manufactures highly potent APIs with containment capabilities in dedicated facilities.
Flow Chemistry
Uses flow chemistry capabilities to support process development and scale-up.
Route Scouting
Supports CMC development by identifying and evaluating synthetic routes.
Process R&D
Performs process research and development for optimization and scale-up of drug substance processes.
Technology Transfer
Transfers developed processes into manufacturing for clinical and commercial production.
Validation
Supports validation activities for processes moving into commercial manufacturing.
Commercial Manufacturing
Manufactures APIs, intermediates, and drug substances at commercial scale.
What they work on
- Modalities
- Small molecule, Peptide, Oligonucleotide
- Assays and studies
- salt screening, polymorph studies, stability studies, analytical development, process safety
- Instruments and platforms
- flow reactors, autoclaves, fume hoods
- Scale and capacity
- 450 KL/M³ manufacturing capacity at Atali, approximately 31,200 litres reactor capacity at Dombivli, 100 MT per month caffeine production capacity at Unit 5, 5,000 TPA xanthine capacity
- Type
- CDMO
- Sites
- Mumbai, India · Navi Mumbai, India · Dombivli, India · Tarapur, India · Vapi, India · Atali, India
- Team
- 2400+ Employees
- Quality
- ISO/IEC 27001:2022 (CDMO R&D Nerul) · USFDA (Dombivli Unit) · USFDA (Tarapur Unit 4) · EUGMP (Tarapur Unit 4) · ANVISA (Tarapur Unit 4) · EDQM (Oncology block at Unit 4) · Cofepris (Unit 4)
- Serves
- USA, European Union, Japan, global
- Founded
- 2022
Public records
Similar labs. Enantia, Porton, SmaBio Labs, WuXi STA
Found in a contract services directory. Listing built from aartipharmalabs.com. Work here? Claim this listing.